Association of Serum miR-186-5p With the Prognosis of Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention

Circulating miR-186-5p is an emerging biomarker for acute coronary syndrome (ACS) patients.However, its kinetic signatures and prognostic values in ACS patients undergoing percutaneous coronary intervention (PCI) remain unclear.Levels of serum miR-186-5p were determined in 96 healthy controls and Electronics - Watches 92 ACS patients before and aft

read more